Recent updates in the clinical use of platinum compounds for the treatment of lung, breast, and genitourinary tumors and myeloma

被引：32
作者：
Belani, CP [1 ]
机构：
[1] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15232 USA
来源：
SEMINARS IN ONCOLOGY | 2004年 / 31卷 / 06期
关键词：
D O I：
10.1053/j.seminoncol.2004.11.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：25 / 33
页数：9
相关论文
共 95 条
[91]   A phase II study of oxaliplatin and paclitaxel in patients with advanced non-small-cell lung cancer [J].
Winegarden, JD ;
Mauer, AM ;
Otterson, GA ;
Rudin, CM ;
Villalona-Calero, MA ;
Lanzotti, VJ ;
Szeto, L ;
Kasza, K ;
Hoffman, PC ;
Vokes, EE .
ANNALS OF ONCOLOGY, 2004, 15 (06) :915-920
[92]  
WINTON TL, 2004, J CLIN ONCOL, V22, P7018
[93]   Involvement of nuclear transcription factor-κB in low-dose doxorubicin-induced drug resistance of cervical carcinoma cells [J].
Yeh, PY ;
Chuang, SE ;
Yeh, KH ;
Song, YC ;
Cheng, AL .
BIOCHEMICAL PHARMACOLOGY, 2003, 66 (01) :25-33
[94]   Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer:: a phase III randomized trial [J].
Zatloukal, P ;
Petruzelka, L ;
Zemanová, M ;
Kolek, V ;
Skricková, J ;
Pesek, M ;
Fojtu, H ;
Grygárková, I ;
Sixtová, D ;
Roubec, J ;
Horenková, E ;
Havel, L ;
Prusa, P ;
Nováková, L ;
Skácel, T ;
Kuta, M .
LUNG CANCER, 2003, 41 (03) :321-331
[95]   Phase II study of oxaliplatin and fluorouracil in taxane- and anthracycline-pretreated breast cancer patients [J].
Zelek, L ;
Cottu, P ;
Tubiana-Hulin, M ;
Vannetzel, JM ;
Chollet, P ;
Misset, JL ;
Chouaki, N ;
Marty, M ;
Gamelin, E ;
Culine, S ;
Dieras, V ;
Mackenzie, S ;
Spielmann, M .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (10) :2551-2558
12345678910